Skip to content

Is the “Cogito” smartphone app a feasible and effective “assistant” to metacognitive training for people with psychosis?

Feasibility of integrating the “Cogito” therapy-homework smartphone app to metacognitive training for people with psychosis; a pilot trial.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622001468718
Enrollment
20
Registered
2022-11-21
Start date
2022-12-01
Completion date
2023-12-01
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We seek to investigate the feasibility of integrating a therapy-homework smartphone app, “Cogito”, into an evidence-based psychological intervention for people with a diagnosis of psychosis. The intervention, individualized metacognitive training (MCT+), is an effective psychological treatment for reducing delusional symptoms in people with psychosis. The app, "Cogito", provides participants with brief once daily reminders of the lessons they learned in therapy sessions. Therapy homework is a core component of psychological therapies, allowing participants to keep practicing the lessons learnt and exercises/experiments covered in sessions outside of therapy session. Compliance with homework has been shown to improve treatment outcomes from therapy. MCT/MCT+ has traditionally used conventional homework sheets. While MCT/MCT+ has been shown to be effective, it has been noted that many patients with psychosis do not complete the homework exercises due to several factors, including forgetfulness and lack of motivation. Delivering therapy ‘homework’ via a smartphone app has the potential to increase engagement and compliance, and ultimately, may further improve the efficacy of interventions such as MCT. The “Cogito” smartphone app was developed to complement MCT/MCT+, with a goal of increasing homework adherence and thus maintaining and increasing the gains from therapy. We hypothesize that participants will find the app useful and will be more likely to complete homework activities using the Cogito app than they would using traditional paper worksheet style homework.

Interventions

This study will implement an evidence-based treatment program for people with schizophrenia (MCT+; metacognitive training). Therapy homework will be delivered via a recently created MCT+ companion smartphone app, Cogito. The study will record how often participants use the homework app between sessions, and assess participants perceptions of the app. MCT+ (Metacognitive Training) teaches participants to “think about their thinking” through a series of collaborative activities and exercises. Th

This study will implement an evidence-based treatment program for people with schizophrenia (MCT+; metacognitive training). Therapy homework will be delivered via a recently created MCT+ companion smartphone app, Cogito. The study will record how often participants use the homework app between sessions, and assess participants perceptions of the app. MCT+ (Metacognitive Training) teaches participants to “think about their thinking” through a series of collaborative activities and exercises. This metacognitive awareness of their thoughts “plants the seeds of doubt” and has been shown to reduce the severity of delusional symptoms in people with psychosis. However, as with all psychological therapies, participants should keep practicing the lessons learnt and exercises/experiments covered in sessions outside of therapy session as ‘homework’; something that remains a logistical challenge, particularly in people with psychosis. Delivering therapy ‘homework’ via a smartphone app has the potential to increase engagement and compliance. However, access to—and a desire to use—suitable smartphone devices or the apps they employ may be limited in people with psychosis. This pilot study will look at the feasibility and acceptance of homework delivered via smartphone in this population. MCT+ will be delivered in one-on-one face-to-face sessions by people with at minimum 4-year psychology degrees, across a period of six weeks, in the form of six sessions (1/week) lasting approximately 60-minutes/session (up to 90-minutes at most): • The initial ‘baseline’ session will assess participants current psychosis symptomology using the relevant sections of standardized, brief, diagnostic interviews (i.e., The Positive and Negative Syndrome Scale (PANSS) for schizophrenia and Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS)). This interview is designed to be as rapid and non-invasive as possible, while still yielding an accurate validation of presumed diagnosis and symptoms. Participants will be introduced to the MCT+ program in this session and be trained in the use of the companion app “Cogito”. During this session, participants will also be asked to complete three short computer-based tasks, designed to measure participants tendency to jump to conclusions (the probabilistic ‘beads task’ where participants make judgments about which jar some coloured beads are being drawn from), belief inflexibility (where participants rate the plausibility of different interpretations across several distinct scenarios) and overconfidence (where participants read words on the screen and make simple confidence judgments about those words – e.g., how confident are you that this word was presented in the previous list of words?). In total, the interview and tasks will last approximately 60-90-minutes to complete. • The following four sessions will present and work though the MCT+ modules. These modules do not have a set order and contain overlapping content. A session involves presenting information about a specific cognitive bias, performing exercises illustrating the bias, and relating the bias to the participants real life experiences. While up to 90-minutes is scheduled for each session, the length is flexible, and substantial learning can occur in shorter sessions. If a participant is unable to attend a session, they will still be offered the full course of six sessions and be able to make up the session either later in the week or the following week. As the content has no set order, and overlaps between sessions, the delivery is very flexible to the weekly life circumstances of the participant. Between sessions participants will be asked to spend 5 minutes a day using the Cogito app. • The final ‘follow-up’ session will repeat the measures from the initial ‘baseline’ session, and participants will evaluate the MCT+ sessions and, importantly, the Cogito app. We seek to test the feasibility of integrating a companion smartphone app called “Cogito” into the established MCT+ program. Cogito is a simple text-based app and is designed to be used as homework between sessions. The app provides a brief daily reminder of the lessons learnt during therapy.). Cogito contains modules specifically designed for MCT/MCT+ for psychosis. The app has once daily exercises that consist of reading 150-200 words of text that remind and reinforce the material learned in sessions (e.g., the app may briefly outline a lesson learned in therapy and ask the participant to think about a situation that may have been applicable in their life). Each exercise is designed to take no more than a few minutes. The app sends optional once daily reminders (via discrete mobile push notifications) when a new exercise is ready. The app records the number of exercises completed and at the end of each week provides participants with a summary. The app can also be personalized by favouriting the most helpful exercises and deleting those that are unhelpful. It is also possible to add your own exercises by using the smartphone camera to take and upload photos. Cogito app use will be monitored using daily SMS surveys to participants, and overall perceptions of the app will be assessed with a study-specific questionnaire in the final (sixth) MCT session.

Sponsors

Flinders University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Must be aged between 18-65 years and have a diagnosis of schizophrenia.

Exclusion criteria

Participants will be excluded if their medical treating team does not believe that they are stable and low-risk, such that they are suitable for, and may potentially benefit from, MCT+ therapy sessions.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026